The imager replacing the pathologist in the diagnosis of hepatobiliary and pancreatic disease

Annals of Diagnostic Pathology

Volumn 5, Issue 1, 2001, Pages 57-66

  Van Leeuwen, Dirk J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cross sectional imaging; Fine needle aspiration; Hepatobiliary disease; Liver biopsy; Pancreatic disease

Indexed keywords

ASPIRATION BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; GALLSTONE; HEPATOBILIARY DISEASE; LIVER BIOPSY; LIVER CIRRHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0035114157     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1053/adpa.2001.22217     Document Type: Review

References (27)

1. Imaging in Hepatobiliary and Pancreatic disease
2. Liver biopsy in the mid-1990s: Questions and answers
3. Staging laparoscopy and laparoscopic ultrasonography in more than 400 patients with upper gastrointestinal cancer
4. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival
5. Standard surgical treatment in pancreatic cancer
6. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct
7. Economics of pancreaticoduodenectomy in the elderly
8. Quality of life and outcome after pancreaticoduodenectomy
9. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer
10. Radical pancreaticoduodenectomy for misdiagnosed pancreatic mass
11. Pretreatment evaluation of chronic hepatitis C: Risks, benefits, and costs
12. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
13. Recovery, persistence, and sequelae in hepatitis C infection: A perspective on long-term outcome
14. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
15. Scoring of liver biopsies: Are we doing it right
16. Fibrosis in patients with chronic hepatitis C: Detection and significance
17. Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at week 4 versus ALT
18. Hemochromatosis: Genetics, pathophysiology, diagnosis and treatment
19. Role of genetic testing and liver biopsy in the diagnosis of hemochromatosis
20. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation
21. Transjugular liver biopsy
22. Hemochromatosis: Diagnosis and quantification of liver iron with gradient-echo MR imaging
23. Liver biopsy: Increased risks in patients with cancer
24. Rising incidence of hepatocellular carcinoma in the United States
25. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy
26. The future of hepatobiliary and pancreatic imaging: Clinical perspectives
27. Evaluation of benign vs malignant hepatic lesions with positron emission tomography